Therapeutic Class
BMS $30bn CAR-T vision boosted by MA plant approval
Therapeutic ClassBMS $30bn CAR-T vision boosted by MA plant approvalBMS $30bn CAR-T vision boosted by MA plant approval
The US FDA has approved a 244,000 square-foot manufacturing plant in Devens, bringing a third CAR-T facility online for BMS.